Latest Bariatrics Stories
Connie K. Ho for redOrbit.com – Your Universe Online If you’re thinking of eating a burger and have the right DNA, you might just get away with eating this fatty culinary delight without doing too much damage to your waistline. Researchers from the Health Sciences Department at the University of California, Los Angeles (UCLA) recently found that genetics can affect the way a person’s body-fat levels react to a fast-food diet. The researchers found a number of genes that they believe...
Connie K. Ho for redOrbit.com – Your Universe Online A new study from the University of North Carolina (UNC) reveals that fussy infants are more likely to spend a greater amount of time in front of the television to help soothe and entertain them. The study focused on mothers, particularly those who were obese, and their parenting of babies that were fussier or more active. The researchers believe that the results of the study could better help them understand the increasing number of...
DALLAS, Jan. 8, 2013 /PRNewswire/ -- The holidays can be a tough time financially, and My Bariatric Solutions wants to ease your financial burdens while keeping you on the right weight loss track by offering BUY ONE, GET ONE FREE on LAP-BAND® Adjustments (BOGO) through March 31, 2013. Dallas bariatric surgeon and Medical Director, Dr. Scott Stowers, is now providing low cost LAP-BAND® adjustments. Pick from "Buy 1 LAP-BAND®adjustment & get 1 free" or you can...
TAMPA, Fla., Jan. 7, 2013 /PRNewswire-USNewswire/ -- The Obesity Action Coalition (OAC) is proud to debut the "Understanding Your Weight-loss Options" brochure. Developed by the nation's leading experts on obesity, excess weight and weight-loss treatments, this 40-page brochure offers readers the most up-to-date information on safe and effective weight-loss options for individuals wanting to address their weight and improve their health. "Researching weight-loss options can be a...
Finding may lead to new treatments for obesity As part of their ongoing research on the physiologic factors that contribute to the development of obesity, Joslin Diabetes Center scientists have identified a cell cycle transcriptional co-regulator – TRIP-Br2 – that plays a major role in energy metabolism and fat storage. This finding has the potential to lead to new treatments for obesity. The study is being published today ahead of print by Nature Medicine. Transcriptional...
redOrbit Staff & Wire Reports - Your Universe Online While experts have long touted proper diet and exercise as ways to stay slim and trim, an international team of researchers have discovered a biological trigger that could pave the way for new way to help overweight individuals overcome their obesity. "In many cases, obesity is caused by more than just overeating and a lack of exercise. Something in the body goes haywire, causing it to store more fat and burn less energy,"...
Diet Doc has released their most advanced prescription-only hCG diet to target childhood obesity in America. New York, NY (PRWEB) January 05, 2013 Childhood Obesity in America has reached the crisis level. Two out of every three Americans are overweight, one in three are obese and the number of overweight teens has more than tripled since the 70’s. Diet Doc’s prescription-only hCG diet plan is an all-inclusive, medically monitored and supervised weight loss plan that provides each...
A recent study published in the Journal of Pediatrics indicates that children in daycare settings have a significantly increased risk of childhood obesity. Programs like fit-Care by Sanford Health & WebMD can help lower prevalence. Sioux Falls, SD (PRWEB) January 05, 2013 A [recent study published in the Journal of Pediatrics indicates that children in daycare settings have a significantly increased risk of childhood obesity. Researchers acknowledged that a child in a daycare setting...
CAMBRIDGE, Mass., Jan. 4, 2013 /PRNewswire/ -- Zafgen, Inc., a leading biopharmaceutical company dedicated to addressing the unmet needs of severely obese patients, today announced the appointment of Patricia Allen, CPA, to the position of Chief Financial Officer, effective immediately. Ms. Allen succeeds Matthias Jaffe, who oversaw financial operations and business development at Zafgen during the series B and C financing of the company. Ms. Allen offers 20 years of financial...
BOSTON, Jan. 4, 2013 /PRNewswire/ -- Rhythm announced today the initiation of a Phase 2 clinical trial with RM-493, the company's novel melanocortin 4 receptor (MC4R) agonist, for the treatment of obesity. "This Phase 2 study will greatly expand our understanding of RM-493's profile for the treatment of obesity," said Liz Stoner, MD, Chief Development Officer of Rhythm. "Based on the data from preclinical studies and early clinical trials, we believe RM-493 has substantial...
